Market Price

54.92 

-0.02 0.0%

as of Apr 18 '19

52 Week Range:

32.65 80.92


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core lab services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in Healthcare, Research, and Corporate and Other segments. The Healthcare segment focuses on the remote cardiac monitoring to identify arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, and non-loop event monitors. It also provides Holter and extended-wear Holter monitors, and INR monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The Corporate and Other segment focuses on the manufacture, engineering, development, and sale of non-invasive cardiac monitors and other population health management devices for healthcare companies, as well as contract manufacturing services under the BioTel Care and BioTel Alliance names. The company was founded in 1994 and is headquartered in Malvern, Pennsylvania.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 6.42
6.23
5.56
5.18
2.78
2.55
2.39
2.62
3.36
8.10
8.85
growth rate -3.0% -10.8% -6.8% -46.3% -8.3% -6.3% 9.6% 28.2% 141.1% 9.3%
Earnings BIT 10.69
-20.47
-19.60
-61.18
-13.11
-7.10
2.79
15.58
26.65
29.67
64.47
growth rate -100.0% 0.0% 0.0% 0.0% 0.0% 100.0% 459.5% 71.1% 11.3% 117.3%
Avg.PE 84.75
-16.40
-7.20
-1.60
-5.00
-4.33
-4.33
46.31
52.31
25.69
139.56
growth rate -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 13.0% -50.9% 443.3%
ROA 4.92
-12.26
-12.22
-48.81
-13.19
-8.24
-9.22
5.97
33.07
-4.41
7.71
growth rate -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 453.9% -100.0% 100.0%
ROE 18.94
-13.67
-13.97
-57.69
-16.49
-10.70
-15.01
10.64
49.75
-8.19
15.26
growth rate -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 367.6% -100.0% 100.0%
ROIC 16.18
-13.79
-14.04
-57.83
-16.56
-10.60
-12.55
7.90
40.50
-2.54
10.83
growth rate -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 412.7% -100.0% 100.0%
Cur. Ratio 6.73
5.31
4.48
4.71
2.35
2.32
1.40
1.97
1.89
1.77
2.96
growth rate -21.1% -15.6% 5.1% -50.1% -1.3% -39.7% 40.7% -4.1% -6.4% 67.2%
Quick Ratio 6.66
5.15
4.22
4.48
2.09
2.06
1.26
1.81
1.58
1.46
2.69
growth rate -22.7% -18.1% 6.2% -53.4% -1.4% -38.8% 43.7% -12.7% -7.6% 84.3%
Leverage 1.10
1.13
1.16
1.22
1.29
1.31
1.96
1.64
1.43
2.09
1.89
growth rate 2.7% 2.7% 5.2% 5.7% 1.6% 49.6% -16.3% -12.8% 46.2% -9.6%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 39.30
40.90
25.00
21.00
20.31
17.12
24.55
24.18
26.86
38.49
52.63
growth rate 4.1% -38.9% -16.0% -3.3% -15.7% 43.4% -1.5% 11.1% 43.3% 36.8%
Acct.Payable 16.30
16.91
13.20
8.50
12.43
14.53
18.16
growth rate 3.8% -22.0% -35.6% 46.3% 16.9% 25.0%
Cur.Assets 98.70
92.90
78.10
72.60
43.42
44.26
49.20
47.05
59.56
90.11
146.66
growth rate -5.9% -15.9% -7.0% -40.2% 1.9% 11.2% -4.4% 26.6% 51.3% 62.8%
Total Assets 165.80
168.30
156.70
95.00
90.01
87.55
124.37
124.14
198.98
524.56
586.80
growth rate 1.5% -6.9% -39.4% -5.3% -2.7% 42.1% -0.2% 60.3% 163.6% 11.9%
Cash 58.20
49.20
18.70
18.50
18.30
22.15
20.01
18.99
23.05
36.02
80.89
growth rate -15.5% -62.0% -1.1% -1.1% 21.1% -9.7% -5.1% 21.4% 56.3% 124.6%
Inventory 0.00
0.00
1.50
2.00
2.89
2.55
2.57
2.38
5.18
5.33
7.32
growth rate 33.3% 44.7% -11.8% 0.5% -7.3% 117.7% 3.0% 37.3%
Cur.Liabilities 14.70
17.50
17.40
15.40
18.49
19.04
35.32
23.89
31.51
50.96
49.62
growth rate 19.1% -0.6% -11.5% 20.1% 3.0% 85.5% -32.4% 31.9% 61.7% -2.6%
Liabilities 15.70
19.00
21.80
17.00
20.01
20.72
60.70
48.22
60.07
274.86
276.32
growth rate 21.0% 14.7% -22.0% 17.7% 3.5% 193.0% -20.6% 24.6% 357.6% 0.5%
LT Debt 0.00
0.00
0.00
0.00
0.00
0.47
22.94
21.94
23.91
197.31
193.42
growth rate 4,790.2% -4.3% 9.0% 725.2% -2.0%
Equity 150.10
149.40
134.90
78.00
70.00
66.83
63.68
75.93
138.91
250.76
310.49
growth rate -0.5% -9.7% -42.2% -10.3% -4.5% -4.7% 19.2% 83.0% 80.5% 23.8%
Common Shares 23.00
24.00
24.00
24.00
25.00
26.00
26.00
29.00
30.00
30.00
36.00
growth rate 4.4% 0.0% 0.0% 4.2% 4.0% 0.0% 11.5% 3.5% 0.0% 20.0%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 11.80
19.94
5.20
4.00
5.96
8.17
12.78
13.60
10.90
13.70
24.64
growth rate 69.0% -73.9% -23.1% 49.1% 37.0% 56.5% 6.4% -19.9% 25.7% 79.9%
Cash Dividends 0.00 0.00 0.00 0.00 0.00
growth rate
Cash From OA 10.31
7.90
10.40
5.00
5.74
11.26
8.81
14.35
38.85
23.78
72.75
growth rate -23.4% 31.7% -51.9% 14.9% 96.1% -21.7% 62.9% 170.7% -38.8% 205.9%
FCF per Share -0.07
-0.51
0.21
0.42
-0.01
0.11
-0.17
-0.06
0.73
0.29
1.10
growth rate 0.0% 100.0% 100.0% -100.0% 100.0% -100.0% 0.0% 100.0% -60.3% 279.3%
Sale Purchase of Stock 0.44
0.85
1.40
1.22
2.52
1.31
growth rate 92.5% 65.3% -12.7% 106.1% -48.2%
FCF -1.00
-12.00
5.00
1.00
-0.20
3.00
-4.00
1.00
28.00
10.00
48.00
growth rate 0.0% 100.0% -80.0% -100.0% 100.0% -100.0% 100.0% 2,700.0% -64.3% 380.0%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 120.50
140.60
119.90
119.00
111.49
129.50
157.23
170.47
198.40
273.49
377.25
growth rate 16.7% -14.7% -0.8% -6.3% 16.2% 21.4% 8.4% 16.4% 37.8% 37.9%
Op.Income 9.70
-20.60
-19.70
-61.30
-12.20
-7.32
2.79
15.58
26.65
29.67
64.47
growth rate -100.0% 0.0% 0.0% 0.0% 0.0% 100.0% 459.5% 71.1% 11.3% 117.3%
IBT 10.70
-20.50
-19.60
-61.20
-13.11
-7.10
-12.11
7.90
15.77
-10.40
41.50
growth rate -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 99.7% -100.0% 100.0%
Net Income 9.20
-20.50
-19.90
-61.40
-12.20
-7.32
-9.79
7.43
53.44
-15.96
42.82
growth rate -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 619.4% -100.0% 100.0%
EPS 0.29
-0.86
-0.82
-2.51
-0.49
-0.29
-0.37
0.26
1.75
-0.53
1.20
growth rate -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 573.1% -100.0% 100.0%
Gross Profit 80.50
91.90
72.40
69.90
65.90
79.07
84.12
98.51
119.52
159.08
228.26
growth rate 14.2% -21.2% -3.5% -5.7% 20.0% 6.4% 17.1% 21.3% 33.1% 43.5%
R&D 4.00
5.80
4.90
5.70
4.66
7.34
7.40
7.11
8.36
11.10
11.21
growth rate 45.0% -15.5% 16.3% -18.2% 57.3% 0.8% -3.9% 17.5% 32.9% 1.0%

Quarterly Statements

Item Name Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Earnings BIT 10.80
10.80
16.04
18.58
19.06
growth rate 0.0% 48.6% 15.9% 2.6%
Balance Sheet Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Acct.Receivable 38.49
47.17
49.93
51.02
52.63
growth rate 22.6% 5.9% 2.2% 3.2%
Acct.Payable 13.23
16.86
13.82
15.50
18.16
growth rate 27.5% -18.1% 12.2% 17.1%
Cur.Assets 90.11
98.40
105.19
133.99
146.66
growth rate 9.2% 6.9% 27.4% 9.5%
Total Assets 524.56
528.03
548.38
574.21
586.80
growth rate 0.7% 3.9% 4.7% 2.2%
Cash 36.02
36.35
39.43
63.12
80.89
growth rate 0.9% 8.5% 60.1% 28.2%
Inventory 5.33
6.35
7.71
8.79
7.32
growth rate 19.2% 21.3% 14.0% -16.7%
Cur.Liabilities 50.96
50.20
45.94
50.09
49.62
growth rate -1.5% -8.5% 9.0% -0.9%
Liabilities 274.86
271.67
275.17
278.69
276.32
growth rate -1.2% 1.3% 1.3% -0.9%
LT Debt 197.31
196.34
195.37
194.40
193.42
growth rate -0.5% -0.5% -0.5% -0.5%
Equity 250.76
258.35
273.20
295.52
310.49
growth rate 3.0% 5.8% 8.2% 5.1%
Common Shares 0.03
0.03
0.03
0.03
0.03
growth rate 3.1% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Capital Expenditures 1.76
3.94
6.00
7.56
7.14
growth rate 124.1% 52.3% 26.0% -5.6%
Cash Dividends
growth rate
Cash From OA 13.12
9.07
7.06
28.15
28.46
growth rate -30.8% -22.2% 298.6% 1.1%
Sale Purchase of Stock 2.49
2.49
3.67
growth rate 0.0% 47.5%
FCF 11.36
5.14
1.06
20.59
21.32
growth rate -54.8% -79.3% 1,837.0% 3.6%
Income Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Sales 87.43
89.62
94.49
94.86
98.29
growth rate 2.5% 5.4% 0.4% 3.6%
Op.Income 10.80
10.80
16.04
18.58
19.06
growth rate 0.0% 48.6% 15.9% 2.6%
IBT -9.72
4.89
8.94
14.72
12.95
growth rate 100.0% 82.8% 64.6% -12.1%
Net Income -15.59
5.98
10.44
16.00
10.39
growth rate 100.0% 74.6% 53.2% -35.1%
EPS
growth rate
Gross Profit 50.11
53.17
58.88
57.58
58.64
growth rate 6.1% 10.7% -2.2% 1.8%
R&D 2.88
3.29
2.73
2.43
2.76
growth rate 14.4% -16.9% -11.1% 13.4%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (77.76)

YOY Growth Grade:

E (23.60)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 49.30 45.77 27.91
EPS / Growth 77.2% 1.20 25.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 29.5%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 25.0% 27.2% 27.2%
Future PE 27.91 43.90 43.90
Future EPS 11.18 13.35 13.35
Value Price
MOS %
77.09
40.4%
144.83
163.7%
144.83
163.7%
MOS Price 38.54 72.41 72.41
IRT 10.36 9.86 9.86

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.